Latest News and Press Releases
Want to stay updated on the latest news?
-
Medpace (NASDAQ:MEDP) may have Committed Securities Fraud after Cancellation Rates Disclosed – Contact BFA Law about the Pending Class Action
-
Medpace Cancellation Rates Trigger Securities Class Action – Investors Alerted to Contact BFA Law
-
Medpace (NASDAQ:MEDP) June 8 Legal Deadline in Securities Class Action is Approaching – Investors with Losses Urged to Contact BFA Law
-
The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.
-
The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.
-
The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.
-
The case alleges Medpace oversold its projected book-to-bill ratio for fourth quarter 2025.